Molecular diagnosis of bacterial vaginosis: An update

Research output: Contribution to journalReview article

Abstract

Bacterial vaginosis (BV) is the most common cause of vaginal discharge in reproductive-age women. BV has been associated with poor reproductive outcomes such as preterm delivery, the acquisition of sexually transmitted infections, including HIV, and pelvic inflammatory disease. BV represents the acquisition of a diverse community of anaerobic and facultative bacteria and a reduction in lactobacilli. It can be diagnosed using several tests ranging from clinical indicators, point-of-care tests, and molecular assays. Molecular technologies are objective, are able to detect fastidious bacteria, enable quantitation, and are ideal for self-collected vaginal swabs. This paper reviews the currently available BV diagnostic tests in the United States.

Original languageEnglish (US)
Article numbere00342
JournalJournal of Clinical Microbiology
Volume56
Issue number9
DOIs
StatePublished - Sep 1 2018

Fingerprint

Bacterial Vaginosis
Point-of-Care Systems
Vaginal Discharge
Pelvic Inflammatory Disease
Anaerobic Bacteria
Lactobacillus
Sexually Transmitted Diseases
Routine Diagnostic Tests
HIV
Technology
Bacteria

Keywords

  • bacterial vaginosis
  • Real-time PCR
  • Vaginal flora

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

Molecular diagnosis of bacterial vaginosis : An update. / Coleman Fennell, Jenell S.; Gaydos, Charlotte A.

In: Journal of Clinical Microbiology, Vol. 56, No. 9, e00342, 01.09.2018.

Research output: Contribution to journalReview article

@article{cf918e2f9d6c40f089ecf7e1c452f69f,
title = "Molecular diagnosis of bacterial vaginosis: An update",
abstract = "Bacterial vaginosis (BV) is the most common cause of vaginal discharge in reproductive-age women. BV has been associated with poor reproductive outcomes such as preterm delivery, the acquisition of sexually transmitted infections, including HIV, and pelvic inflammatory disease. BV represents the acquisition of a diverse community of anaerobic and facultative bacteria and a reduction in lactobacilli. It can be diagnosed using several tests ranging from clinical indicators, point-of-care tests, and molecular assays. Molecular technologies are objective, are able to detect fastidious bacteria, enable quantitation, and are ideal for self-collected vaginal swabs. This paper reviews the currently available BV diagnostic tests in the United States.",
keywords = "bacterial vaginosis, Real-time PCR, Vaginal flora",
author = "{Coleman Fennell}, {Jenell S.} and Gaydos, {Charlotte A}",
year = "2018",
month = "9",
day = "1",
doi = "10.1128/JCM.00342-1",
language = "English (US)",
volume = "56",
journal = "Journal of Clinical Microbiology",
issn = "0095-1137",
publisher = "American Society for Microbiology",
number = "9",

}

TY - JOUR

T1 - Molecular diagnosis of bacterial vaginosis

T2 - An update

AU - Coleman Fennell, Jenell S.

AU - Gaydos, Charlotte A

PY - 2018/9/1

Y1 - 2018/9/1

N2 - Bacterial vaginosis (BV) is the most common cause of vaginal discharge in reproductive-age women. BV has been associated with poor reproductive outcomes such as preterm delivery, the acquisition of sexually transmitted infections, including HIV, and pelvic inflammatory disease. BV represents the acquisition of a diverse community of anaerobic and facultative bacteria and a reduction in lactobacilli. It can be diagnosed using several tests ranging from clinical indicators, point-of-care tests, and molecular assays. Molecular technologies are objective, are able to detect fastidious bacteria, enable quantitation, and are ideal for self-collected vaginal swabs. This paper reviews the currently available BV diagnostic tests in the United States.

AB - Bacterial vaginosis (BV) is the most common cause of vaginal discharge in reproductive-age women. BV has been associated with poor reproductive outcomes such as preterm delivery, the acquisition of sexually transmitted infections, including HIV, and pelvic inflammatory disease. BV represents the acquisition of a diverse community of anaerobic and facultative bacteria and a reduction in lactobacilli. It can be diagnosed using several tests ranging from clinical indicators, point-of-care tests, and molecular assays. Molecular technologies are objective, are able to detect fastidious bacteria, enable quantitation, and are ideal for self-collected vaginal swabs. This paper reviews the currently available BV diagnostic tests in the United States.

KW - bacterial vaginosis

KW - Real-time PCR

KW - Vaginal flora

UR - http://www.scopus.com/inward/record.url?scp=85052515328&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052515328&partnerID=8YFLogxK

U2 - 10.1128/JCM.00342-1

DO - 10.1128/JCM.00342-1

M3 - Review article

C2 - 29769280

AN - SCOPUS:85052515328

VL - 56

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

SN - 0095-1137

IS - 9

M1 - e00342

ER -